Background Consensus criteria for classifying tremor disorders were published by the
International Parkinson and Movement Disorder Society in 1998. Subsequent advances with …

Dystonia is a clinically and genetically highly heterogeneous neurological disorder
characterized by abnormal movements and postures caused by involuntary sustained or …

Background Dystonia is a clinically and genetically heterogeneous condition that occurs in
isolation (isolated dystonia), in combination with other movement disorders (combined …

Este artigo analisa a trajetória de construção de políticas públicas para a agricultura familiar
no Brasil, procurando enfatizar as" gerações" ou referenciais de políticas públicas …

Abstract Involuntary movements develop after 1–4% of strokes and they have been reported
in patients with ischemic and hemorrhagic strokes affecting the basal ganglia, thalamus …

In a range of neurological conditions, including movement disorders, sex-related differences
are emerging not only in brain anatomy and function, but also in pathogenesis, clinical …

The system of assigning locus symbols to specify chromosomal regions that are associated
with a familial disorder has a number of problems when used as a reference list of …

Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of
blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a …

Botulinum toxin (BoNT) has been used for the treatment of a variety of neurologic, medical
and cosmetic conditions. Two serotypes, type A (BoNT-A) and type B (BoNT-B), are currently …

Summary X-linked Dystonia-Parkinsonism (XDP) is a Mendelian neurodegenerative
disease that is endemic to the Philippines and is associated with a founder haplotype. We …